2023 - Research.com Immunology in Austria Leader Award
2022 - Research.com Immunology in Austria Leader Award
His primary areas of study are Virology, Antibody, Monoclonal antibody, Epitope and Virus. His Virology research includes elements of RNA and Immunology. Hermann Katinger works mostly in the field of Antibody, limiting it down to concerns involving Immune system and, occasionally, HIV vaccine, Microarray analysis techniques and Mannose.
He combines subjects such as Pharmacokinetics, Neutralization, Conserved sequence, Antigen and Cyanovirin-N with his study of Monoclonal antibody. His Epitope research is multidisciplinary, relying on both Molecular biology and Glycoprotein. His Virus study combines topics from a wide range of disciplines, such as In vitro, Immunogenicity and Polyclonal antibodies.
His primary scientific interests are in Virology, Monoclonal antibody, Molecular biology, Antibody and Cell culture. His Virology study integrates concerns from other disciplines, such as Immunization, Immunology and Antigen. His studies deal with areas such as Epitope, Chromatography and In vitro as well as Monoclonal antibody.
His Molecular biology research incorporates elements of Recombinant DNA and Blot. The Antibody study combines topics in areas such as In vivo, Immune system and Glycoprotein. His Cell culture research integrates issues from Biochemistry, Cell growth and Cell biology.
Chinese hamster ovary cell, Molecular biology, Virology, Antibody and Recombinant DNA are his primary areas of study. His biological study spans a wide range of topics, including Telomere, DNA repair and Blot. The various areas that Hermann Katinger examines in his Virology study include Immunology and Antigen.
Monoclonal antibody, Epitope, Neutralization and Neutralizing antibody are among the areas of Antibody where the researcher is concentrating his efforts. As a part of the same scientific family, he mostly works in the field of Monoclonal antibody, focusing on In vivo and, on occasion, Immune system. His Epitope study incorporates themes from In vitro and Polyclonal antibodies.
His main research concerns Antibody, Virology, Immunology, Chinese hamster ovary cell and Monoclonal antibody. His Antibody research is multidisciplinary, relying on both Molecular biology and Yeast. His Virology research is mostly focused on the topic Virus.
His Chinese hamster ovary cell research integrates issues from Cell, Recombinant DNA and Biopharmaceutical. In his study, Electrophoretic mobility shift assay, Protein A and Linear epitope is strongly linked to Ectodomain, which falls under the umbrella field of Monoclonal antibody. His Epitope research focuses on Gp41 in particular.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies.
John R. Mascola;Gabriela Stiegler;Thomas C. VanCott;Hermann Katinger.
Nature Medicine (2000)
Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1.
A Trkola;M Purtscher;T Muster;C Ballaun.
Journal of Virology (1996)
A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1.
T Muster;F Steindl;M Purtscher;A Trkola.
Journal of Virology (1993)
Protection of Macaques against Pathogenic Simian/Human Immunodeficiency Virus 89.6PD by Passive Transfer of Neutralizing Antibodies
John R. Mascola;Mark G. Lewis;Gabriela Stiegler;Dawn Harris.
Journal of Virology (1999)
HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites
Peter D. Kwong;Peter D. Kwong;Michael L. Doyle;Michael L. Doyle;David J. Casper;Claudia Cicala.
Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection.
Timothy W. Baba;Vladimir Liska;Regina Hofmann-Lehmann;Josef Vlasak.
Nature Medicine (2000)
Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41.
Michael B. Zwick;Aran F. Labrijn;Meng Wang;Catherine Spenlehauer.
Journal of Virology (2001)
Antibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition
Daniel A. Calarese;Christopher N. Scanlan;Michael B. Zwick;Songpon Deechongkit.
Comprehensive Cross-Clade Neutralization Analysis of a Panel of Anti-Human Immunodeficiency Virus Type 1 Monoclonal Antibodies
James M. Binley;Terri Wrin;Bette Korber;Michael B. Zwick.
Journal of Virology (2004)
The Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2G12 Recognizes a Cluster of α1→2 Mannose Residues on the Outer Face of gp120
Christopher N. Scanlan;Ralph Pantophlet;Mark R. Wormald;Erica Ollmann Saphire.
Journal of Virology (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: